Skip to content

Effects of Smartphone Application-Based Integrated Self-Care Support System for Hypertensive Patients

Effects of Smartphone Application-Based Integrated Self-Care Support System for Hypertensive Patients - AppCare-HT Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035898
Enrollment
360
Registered
2019-02-18
Start date
2019-02-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Application group Non-application group (control group)

Sponsors

Hokkaido University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hypertensive patients whose blood pressure at the clinic or physical check-up is more than 140/90mmHg irrespective of taking antihypertensive agents

Exclusion criteria

Exclusion criteria: 1.A patient who cannot use smartphone application 2.A patient diagonized as secondary hypertension 3.A patient with chronic atrial fibrillation 4.A patient with severe renal failure (eGFR<15mL/min/1.73m2) or a dialysis patient 5.A patient who has a history of major cardiovascular events within the past 3 months 6.A patient whose antihypertensive medication was changed within the past 1 month 7.A patient who has a plan of hospitalization due to surgery or examination at the time of study participation 8.A patient who is using another smartphone application for hypertension at the time of study participation 9.A patients who is judged as inappropriate for the study participation by the principal investigator

Design outcomes

Primary

MeasureTime frame
Change in systolic blood pressure from baseline to 12 months

Secondary

MeasureTime frame
1.Change in systolic blood pressure from baseline to 6 months 2.Change in diastolic blood pressure from baseline to each follow-up point (6 months and 12 months) 3.Change in frequency of blood pressure measurements at home from baseline to each follow-up point (6 months and 12 months) 4.Systolic blood pressure 5.Diastolic blood pressure 6.Frequency of blood pressure measurements at home 7.Quality of life (EQ-5D-5L) 8.Self-efficacy (GSES) 9.Medication-taking adherence (MMAS-4) 10.Medical cost 11.Adverse events 12.Change in number or dosage of antihypertensive medicine 13.Days until change of antihypertensive medicine after the start of clinical study 14.Self-monitoring data 15.Frequency of use of smartphone application

Countries

Japan

Contacts

Public ContactTakashi Yokota

Hokkaido University Hospital Institute of Health Science Innovation for Medical Care

t-yokota@med.hokudai.ac.jp011-706-6001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026